EZH2 and neoplasm: When EZH2 is absent or inhibited in regulatory T cells, their ability to suppress effector T cells was blocked, increasing intratumoral levels of effector T cells, and reducing tumor growth (Goswami et al., 2018; Wang et al., 2018).